分子动力学模拟软体市场－全球产业规模、份额、趋势、机会、预测：按类型、应用、最终用户、地区和竞争对手划分，2021-2031年

全球分子动力学模拟软体市场预计将从 2025 年的 6.6213 亿美元成长到 2031 年的 15.3635 亿美元，复合年增长率为 15.06%。

该软体作为一个计算框架，透过数值求解牛顿运动方程式来模拟原子和分子的物理运动，并预测系统在特定时限内的行为。市场成长的主要驱动因素是製药业迫切需要加速药物研发进程，以及化学工程领域对精确材料表征的需求。此外，高效能运算基础设施的日益普及使得研究机构能够更精确地模拟大规模的生物系统，从而减少对资本密集物理实验的依赖。

儘管取得了这些进展，但生命科学产业在管理和维护模拟过程中产生的大型复杂资料集方面仍面临着巨大的挑战。根据皮斯托亚联盟的数据，到2024年，52%的生命科学专业人士会将低品质、管理不善的数据集视为有效采用先进计算研究技术的主要障碍。因此，确保资料完整性和互通性的陡峭学习曲线仍然是一个重大障碍，可能会阻碍市场成长和应用。

市场驱动因素

药物发现和设计领域模拟工具的广泛应用正在从根本上重塑市场格局。企业正优先采用计算方法来降低传统临床试验的高失败率。透过利用分子动力学模拟受体结合亲和性，企业可以在研发週期的早期阶段识别出有前景的候选药物，从而显着降低研发成本。这种向虚拟实验的策略转变，得益于生技公司对模拟技术的大规模投资。例如，Xaira Therapeutics在2024年4月的新闻稿中宣布，已获得10亿美元的资金筹措，用于建立一个将生物数据生成与先进模拟产品开发相结合的平台，旨在重新定义药物发现流程。

同时，人工智慧和机器学习演算法的融合提高了分子运动预测的准确性，并显着缩短了计算时间。这些混合工作流程使研究人员能够避免传统的穷举计算，从而快速分析更大、更复杂的系统。根据谷歌2024年5月发布的关于AlphaFold 3的技术博客，该公司更新后的模型与专用的基于物理的软体工具相比，将蛋白质-配体相互作用的准确率提高了50%。这种效率在先进材料工程等众多市场应用中至关重要。 2024年，微软报告称，其Azure Quantum Elements平台利用高性能人工智慧在短短80小时内筛检了3,200万种潜在的无机材料，展现了该技术为产业带来的快速扩充性。

市场挑战

管理和组织庞大而复杂的资料集的难度是限制全球分子动力学模拟软体市场扩张的主要阻碍因素。随着计算工具的进步，海量输出资料不断涌现，但要将其保持为可用于未来研究的状态，则需要严格的组织和标准化。如果机构无法建立整合的资料管理框架，关键的研究资讯就会被困在孤立的系统中，导致难以检验模拟结果和有效训练预测模型。这种分散化迫使调查团队将宝贵的时间用于手动资料校正，而非进行高价值的发现，从而显着降低了这些软体解决方案所承诺的运作效率。

这种低效性为潜在买家带来了巨大的进入门槛和扩充性障碍。根据皮斯托亚联盟（Pistoia Alliance）预测，到2025年，57%的生命科学专业人士将把资料孤岛视为有效利用实验室资料的最大障碍。这些资料孤岛阻碍了高阶模拟所需的资讯无缝流动，使得决策者不愿投资购买高阶软体授权。因此，企业优先考虑修復基础架构而非采用先进的类比技术，从而减缓了市场成长。

市场趋势

采用GPU加速的平行处理架构从根本上改变了分子动力学的运算环境，使其能够以更高的吞吐量模拟大规模的生物系统。供应商正在加速优化资料中心GPU，以处理计算显式溶剂模型中原子间作用力所需的大规模并行处理，从而克服传统基于CPU的丛集的延迟限制。这项硬体进步使研究团队能够对复杂的聚合物结构（例如整个病毒衣壳）进行微秒模拟，而这在以前被认为在计算上是不可能的。根据Exxact公司2025年9月发布的「AMBER 24 NVIDIA GPU基准测试」报告，NVIDIA B200 SXM GPU在模拟卫星烟草花叶病毒系统时，每天的运行时间达到了114奈秒，比RTX 4090快了40%。

同时，向基于云端的高效能运算平台的转变，正在普及这些先进的模拟能力，并解决管理Petabyte级轨迹资料的关键挑战。透过将工作负载迁移到云端，组织可以利用弹性基础设施来满足不断增长的模拟需求，而无需投入大量资金维护本地超级电脑，同时还能集中存取标准化的公开资料集。这种转变正在推动开放科学的新时代，大规模的模拟资料储存库直接託管在云端服务上，从而促进全球协作和演算法训练。例如，亚马逊网路服务（AWS）于2025年10月宣布向AWS开放资料註册表发布一个包含超过16,000个蛋白质-配体复合物分子动力学轨蹟的综合储存库，以加速基于云端的研究。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球分子动力学模拟软体市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（GPU加速、CPU专用）
  • 依应用领域（化学研究、医学研究、材料研究、生物物理研究）
  • 依最终用户（製药实验室、研究机构、学术用户、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美分子动力学模拟软体市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲分子动力学模拟软体市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区分子动力学模拟软体市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲分子动力学模拟软体市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲分子动力学模拟软体市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球分子动力学模拟软体市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• SchrOdinger, Inc.
• Dassault Systemes SE
• Cadence Design Systems, Inc.
• Bio-Rad Laboratories, Inc.
• Optibrium, Ltd.
• Chemical Computing Group ULC
• GROMACS
• CD ComputaBio
• Simulations Plus, Inc.
• Cresset Biomolecular Discovery Limited

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Molecular Dynamics Simulation Software Market is projected to increase from USD 662.13 Million in 2025 to USD 1536.35 Million by 2031, expanding at a CAGR of 15.06%. This software functions as a computational framework that predicts system behavior over specific timeframes by numerically solving Newton's equations of motion to model the physical movements of atoms and molecules. Market growth is primarily fueled by the urgent need for accelerated drug discovery pipelines in the pharmaceutical industry and the demand for precise material characterization in chemical engineering. Additionally, the growing availability of high-performance computing infrastructure enables facilities to simulate larger biological systems with higher fidelity, thereby reducing the reliance on capital-intensive physical experimentation.

Despite these advancements, the industry encounters significant hurdles regarding the curation and management of the massive, complex datasets produced during simulations. Data from the Pistoia Alliance indicates that in 2024, 52% of life science professionals cited low-quality and poorly curated datasets as the main barrier to the effective implementation of advanced computational research technologies. Consequently, the steep learning curve associated with ensuring data integrity and interoperability remains a critical obstacle that could potentially stall broader market scalability and adoption.

Market Driver

The surging adoption of simulation tools in pharmaceutical drug discovery and design is fundamentally reshaping the market, as companies prioritize computational methods to mitigate the high attrition rates associated with physical clinical trials. By leveraging molecular dynamics to simulate receptor-binding affinities, organizations can identify viable candidates earlier in the R&D cycle, which significantly lowers development costs. This strategic shift toward virtual experimentation is evidenced by substantial capital investments in simulation-focused biotech entities; for instance, Xaira Therapeutics announced in an April 2024 press release that it secured $1 billion in committed capital to build a platform that integrates biological data generation with advanced simulation product development to redefine the drug discovery pipeline.

In parallel, the integration of AI and machine learning algorithms is enhancing the predictive accuracy of molecular movements while drastically reducing computational time. These hybrid workflows allow researchers to bypass traditional brute-force calculations, enabling the rapid analysis of larger and more complex systems. According to a May 2024 technical blog by Google regarding 'AlphaFold 3,' their updated model demonstrated a 50% improvement in accuracy for protein-ligand interactions compared to specialized physics-based software tools. This efficiency is critical for broader market applications, such as advanced material engineering; Microsoft reported in 2024 that its Azure Quantum Elements platform utilized high-performance AI to screen 32 million potential inorganic materials in just 80 hours, showcasing the rapid scalability available to the industry.

Market Challenge

The difficulty of managing and curating massive, complex datasets acts as a primary restraint hindering the expansion of the Global Molecular Dynamics Simulation Software Market. As computational tools become more powerful, they generate vast quantities of output data that require rigorous organization and standardization to remain useful for future research. When organizations fail to establish cohesive data management frameworks, critical research information becomes trapped in isolated systems, making it difficult to validate simulation results or effectively train predictive models. This fragmentation forces research teams to spend valuable time on manual data rectification rather than high-value discovery, significantly reducing the operational efficiency that these software solutions promise to deliver.

This inefficiency creates a substantial barrier to entry and scalability for potential buyers. According to the Pistoia Alliance, in 2025, 57% of life science professionals identified data silos as the top challenge preventing the effective use of laboratory data. Because these silos impede the seamless flow of information required for advanced simulations, decision-makers are often reluctant to invest in premium software licenses. Consequently, the market experiences dampened growth rates as companies prioritize basic infrastructure remediation over the adoption of advanced simulation technologies.

Market Trends

The adoption of GPU-accelerated parallel processing architectures is fundamentally altering the computational landscape for molecular dynamics by enabling the simulation of larger biological systems with superior throughput. Hardware vendors are increasingly optimizing data center GPUs to handle the massive parallelization required for calculating inter-atomic forces in explicit solvent models, thereby overcoming the latency limitations of traditional CPU-based clusters. This hardware evolution allows research teams to execute microsecond-scale simulations of complex macromolecular structures, such as entire viral capsids, which were previously computationally prohibitive. According to Exxact Corporation's September 2025 'AMBER 24 NVIDIA GPU Benchmarks' report, the NVIDIA B200 SXM GPU delivered a simulation performance of 114 nanoseconds per day for the Satellite Tobacco Mosaic Virus system, representing a 40% speed increase compared to the RTX 4090.

Simultaneously, the migration to cloud-based high-performance computing platforms is democratizing access to these advanced simulation capabilities while solving the critical challenge of managing petabyte-scale trajectory data. By shifting workloads to the cloud, organizations can leverage elastic infrastructure to accommodate bursty simulation demands without the capital expenditure of maintaining on-premise supercomputers, while also gaining centralized access to standardized public datasets. This transition is fostering a new era of open science where massive repositories of simulation data are hosted directly on cloud services to facilitate global collaboration and algorithm training. For example, Amazon Web Services announced in October 2025 that it had released a comprehensive repository in the Registry of Open Data on AWS, featuring molecular dynamics trajectories for over 16,000 protein-ligand complexes to accelerate cloud-based research.

Key Market Players

• SchrOdinger, Inc.
• Dassault Systemes S.E.
• Cadence Design Systems, Inc.
• Bio-Rad Laboratories, Inc.
• Optibrium, Ltd.
• Chemical Computing Group ULC
• GROMACS
• CD ComputaBio
• Simulations Plus, Inc.
• Cresset Biomolecular Discovery Limited

Report Scope

In this report, the Global Molecular Dynamics Simulation Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Dynamics Simulation Software Market, By Type

• GPU-Accelerated
• Working Only on CPU

Molecular Dynamics Simulation Software Market, By Application

• Chemical Research
• Medical Research
• Material Science Research
• Biophysics Research

Molecular Dynamics Simulation Software Market, By End-user

• Pharmaceutical Labs
• Research Institutes
• Academic Users
• Others

Molecular Dynamics Simulation Software Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Molecular Dynamics Simulation Software Market.

Available Customizations:

Global Molecular Dynamics Simulation Software Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Dynamics Simulation Software Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (GPU-Accelerated, Working Only on CPU)
  • 5.2.2. By Application (Chemical Research, Medical Research, Material Science Research, Biophysics Research)
  • 5.2.3. By End-user (Pharmaceutical Labs, Research Institutes, Academic Users, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Molecular Dynamics Simulation Software Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End-user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Molecular Dynamics Simulation Software Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-user
  • 6.3.2. Canada Molecular Dynamics Simulation Software Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-user
  • 6.3.3. Mexico Molecular Dynamics Simulation Software Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-user

7. Europe Molecular Dynamics Simulation Software Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End-user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Molecular Dynamics Simulation Software Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-user
  • 7.3.2. France Molecular Dynamics Simulation Software Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-user
  • 7.3.3. United Kingdom Molecular Dynamics Simulation Software Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-user
  • 7.3.4. Italy Molecular Dynamics Simulation Software Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-user
  • 7.3.5. Spain Molecular Dynamics Simulation Software Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-user

8. Asia Pacific Molecular Dynamics Simulation Software Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End-user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Molecular Dynamics Simulation Software Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-user
  • 8.3.2. India Molecular Dynamics Simulation Software Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-user
  • 8.3.3. Japan Molecular Dynamics Simulation Software Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-user
  • 8.3.4. South Korea Molecular Dynamics Simulation Software Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-user
  • 8.3.5. Australia Molecular Dynamics Simulation Software Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-user

9. Middle East & Africa Molecular Dynamics Simulation Software Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End-user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Molecular Dynamics Simulation Software Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-user
  • 9.3.2. UAE Molecular Dynamics Simulation Software Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-user
  • 9.3.3. South Africa Molecular Dynamics Simulation Software Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-user

10. South America Molecular Dynamics Simulation Software Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End-user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Molecular Dynamics Simulation Software Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-user
  • 10.3.2. Colombia Molecular Dynamics Simulation Software Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-user
  • 10.3.3. Argentina Molecular Dynamics Simulation Software Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Molecular Dynamics Simulation Software Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. SchrOdinger, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Dassault Systemes S.E.
• 15.3. Cadence Design Systems, Inc.
• 15.4. Bio-Rad Laboratories, Inc.
• 15.5. Optibrium, Ltd.
• 15.6. Chemical Computing Group ULC
• 15.7. GROMACS
• 15.8. CD ComputaBio
• 15.9. Simulations Plus, Inc.
• 15.10. Cresset Biomolecular Discovery Limited

16. Strategic Recommendations

17. About Us & Disclaimer